Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × enzalutamide × Clear all

Phase

Status

Recruiting 9 Completed 6 Terminated 5 Not yet recruiting 3 Active not recruiting 3 Withdrawn 2 Unknown 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Lenalidomide 2 irinotecan sucrosofate 1 enzalutamide 1 Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Mannitol 1 Leukocyte Count 1 Irinotecan 1 Folfox protocol 1 Dexamethasone 1 Cyclophosphamide 1 Carboplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145375 2025-03-19

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Zenith Epigenetics

Phase 1/2 Enrolling by invitation

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡